Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Raveena, Kantamneni"'
Autor:
Jill Kolesar, Spencer Peh, Levin Thomas, Gayathri Baburaj, Nayonika Mukherjee, Raveena Kantamneni, Shirley Lewis, Ananth Pai, Karthik S. Udupa, Naveena Kumar AN, Vivek M. Rangnekar, Mahadev Rao
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-22 (2022)
Abstract The advent of molecular profiling has revolutionized the treatment of lung cancer by comprehensively delineating the genomic landscape of the epidermal growth factor receptor (EGFR) gene. Drug resistance caused by EGFR mutations and genetic
Externí odkaz:
https://doaj.org/article/1f5edd8ffa8246c4a8eba583dadef412
Autor:
Ramadugula, Suhita, Izwath, Begum, Muhammed, Rashid, Viji Pulikkel, Chandran, Sanjana Aditya, Shastri, Raveena, Kantamneni, Asha K, Rajan, Girish, Thunga
Publikováno v:
Eastern Mediterranean Health Journal. 28:909-916
The World Health Organization estimates that there are approximately 5.4 million snakebites and 1.8-2.7 million cases of envenomation, with 81 410-137 880 deaths each year worldwide.To estimate the prevalence of neurotoxic and haemotoxic snakebite en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae071c261d273296c056781c6e965098
https://doi.org/10.26719/emhj.22.090
https://doi.org/10.26719/emhj.22.090
Autor:
Girish Thunga, Sreedharan Nair, Izwath Begum, Ramadugula Suhita, Viji Pulikkel Chandran, Muhammed Rashid, Raveena Kantamneni, Sanjana Aditya Shastri
Publikováno v:
Medicine and Pharmacy Reports. 95:357-369
Background and objective. Proton Pump Inhibitors (PPIs) reduce gastric acid production and they are indicated for myriad gastrointestinal conditions. Prolonged use of PPI has been linked to the risk of inflammatory bowel disease (IBD) though this fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81bc54cf8e4472dccfffcd2775c62f83
https://doi.org/10.15386/mpr-2259
https://doi.org/10.15386/mpr-2259
Autor:
Jill Kolesar, Spencer Peh, Levin Thomas, Gayathri Baburaj, Nayonika Mukherjee, Raveena Kantamneni, Shirley Lewis, Ananth Pai, Karthik S. Udupa, Naveena Kumar AN, Vivek M. Rangnekar, Mahadev Rao
Publikováno v:
Molecular cancer. 21(1)
The advent of molecular profiling has revolutionized the treatment of lung cancer by comprehensively delineating the genomic landscape of the epidermal growth factor receptor (EGFR) gene. Drug resistance caused by EGFR mutations and genetic polymorph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7940d5cc22f5a4ce6f4c93da101df298
https://pubmed.ncbi.nlm.nih.gov/35209919
https://pubmed.ncbi.nlm.nih.gov/35209919